Anti-inflammatory treatments during the chronic phase of spinal cord injury improve locomotor function in adult mice

Journal of Neurotrauma

Volumn 28, Issue 9, 2011, Pages 1995-2002

  Arnold, Sheila A ^a,b   Hagg, Theo ^a,b  

^a UNIVERSITY OF LOUISVILLE   (United States)

^b University of Louisville School of Medicine   (United States)

Author keywords

CD25; contusion; inflammation; microglia; minocycline

Indexed keywords

ANTIBODY; CD68 ANTIGEN; MINOCYCLINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BRAIN CONTUSION; CLINICAL ASSESSMENT TOOL; CONTROLLED STUDY; DISEASE MARKER; FEMALE; HINDLIMB; INFLAMMATION; INJURY SEVERITY; LOCOMOTION; LYMPHOCYTE FUNCTION; MACROPHAGE; MICROGLIA; MOUSE; NONHUMAN; REGULATORY T LYMPHOCYTE; SPINAL CORD INJURY; WALKING; WHITE MATTER;

ANIMALS; ANTI-INFLAMMATORY AGENTS; FEMALE; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; MACROPHAGES; MICE; MICROGLIA; MINOCYCLINE; MOTOR ACTIVITY; NERVE FIBERS, MYELINATED; RECOVERY OF FUNCTION; SPINAL CORD; SPINAL CORD INJURIES; T-LYMPHOCYTES, REGULATORY;

EID: 80054816436     PISSN: 08977151     EISSN: 15579042     Source Type: Journal    
DOI: 10.1089/neu.2011.1888     Document Type: Article

References (49)

1. Alexander, J.K., and Popovich, P.G. (2009). Neuroinflammation in spinal cord injury: Therapeutic targets for neuroprotection and regeneration. Prog. Brain Res. 175, 125-137.
2. Ankeny, D.P., Guan, Z., and Popovich, P.G. (2009). B cells produce pathogenic antibodies and impair recovery after spinal cord injury in mice. J. Clin. Invest. 119, 2990-2999.
3. Barrette, B., Vallieres, N., Dube, M., and Lacroix, S. (2007). Expression profile of receptors for myelin-associated inhibitors of axonal regeneration in the intact and injured mouse central nervous system. Mol. Cell. Neurosci. 34, 519-538.
4. Basso, D.M., Fisher, L.C., Anderson, A.J., Jakeman, L.B., McTigue, D.M., and Popovich, P.G. (2006). Basso Mouse Scale for locomotion detects differences in recovery after spinal cord injury in five common mouse strains. J. Neurotrauma 23, 635-659.
5. Blight, A.R. (1985). Delayed demyelination and macrophage invasion: A candidate for secondary cell damage in spinal cord injury. Cent. Nerv. Syst. Trauma 2, 299-315.
6. Blight, A.R. (1992). Macrophages and inflammatory damage in spinal cord injury. J. Neurotrauma 9, Suppl. 1, S83-S91.
7. Blight, A.R. (1994). Effects of silica on the outcome from experimental spinal cord injury: Implication of macrophages in secondary tissue damage. Neuroscience 60, 263-273.
8. Davies, A.L., Hayes, K.C., and Shi, R. (2006). Recombinant human TNFalpha induces concentration-dependent and reversible alterations in the electrophysiological properties of axons in mammalian spinal cord. J. Neurotrauma 23, 1261-1273.
9. de Rivero Vaccari, J.P. Lotocki, G., Marcillo, A.E., Dietrich, W.D., and Keane, R.W. (2008) A molecular platform in neurons regulates inflammation after spinal cord injury, J. Neurosci. 28, 3404-3414.
10. Donnelly, D.J., Gensel, J.C., Ankeny, D.P., van, R.N., and Popovich, P.G. (2009). An efficient and reproducible method for quantifying macrophages in different experimental models of central nervous system pathology. J. Neurosci. Methods 181, 36-44.
11. Donnelly, D.J., and Popovich, P.G. (2008). Inflammation and its role in neuroprotection, axonal regeneration and functional recovery after spinal cord injury. Exp. Neurol. 209, 378-388.
12. Fecci, P.E., Sweeney, A.E., Grossi, P.M., Nair, S.K., Learn, C.A., Mitchell, D.A., Cui, X., Cummings, T.J., Bigner, D.D., Gilboa, E., and Sampson, J.H. (2006). Systemic anti-CD25 monoclonal antibody administration safely enhances immunity in murine glioma without eliminating regulatory T cells. Clin. Cancer Res. 12, 4294-4305.
13. Festoff, B.W., Ameenuddin, S., Arnold, P.M., Wong, A., Santacruz, K.S., and Citron, B.A. (2006). Minocycline neuroprotects, reduces microgliosis, and inhibits caspase protease expression early after spinal cord injury. J. Neurochem. 97, 1314-1326.
14. Fleming, J.C., Norenberg, M.D., Ramsay, D.A., Dekaban, G.A., Marcillo, A.E., Saenz, A.D., Pasquale-Styles, M., Dietrich, W.D., and Weaver, L.C. (2006). The cellular inflammatory response in human spinal cords after injury. Brain 129, 3249-3269.
15. Ghasemlou, N., Jeong, S.Y., Lacroix, S., and David, S. (2007). T cells contribute to lysophosphatidylcholine-induced macrophage activation and demyelination in the CNS. Glia 55, 294-302.
16. Ghasemlou, N., Kerr, B.J., and David, S. (2005). Tissue displacement and impact force are important contributors to outcome after spinal cord contusion injury. Exp. Neurol. 196, 9-17.
17. Gonzalez, R., Hickey, M.J., Espinosa, J.M., Nistor, G., Lane, T.E., and Keirstead, H.S. (2007). Therapeutic neutralization of CXCL10 decreases secondary degeneration and functional deficit after spinal cord injury in mice. Regen. Med. 2, 771-783.
18. Gris, D., Marsh, D.R., Oatway, M.A., Chen, Y., Hamilton, E.F., Dekaban, G.A., and Weaver, L.C. (2004). Transient blockade of the CD11d/CD18 integrin reduces secondary damage after spinal cord injury, improving sensory, autonomic, and motor function. J. Neurosci. 24, 4043-4051.
19. Hains, B.C., and Waxman, S.G. (2006). Activated microglia contribute to the maintenance of chronic pain after spinal cord injury. J. Neurosci. 26, 4308-4317.
20. Han, S., Arnold, S.A., Sithu, S.D., Mahoney, E.T., Geralds, J.T., Tran, P., Benton, R.L., Maddie, M.A., D'Souza, S.E., Whittemore, S.R., and Hagg, T. (2010). Rescuing vasculature with intravenous angiopoietin-1 and alpha v beta 3 integrin peptide is protective after spinal cord injury. Brain 133, 1026-1042.
21. Kigerl, K.A., Gensel, J.C., Ankeny, D.P., Alexander, J.K., Donnelly, D.J., and Popovich, P.G. (2009). Identification of two distinct macrophage subsets with divergent effects causing either neurotoxicity or regeneration in the injured mouse spinal cord. J. Neurosci. 29, 13,435-13,444.
22. Kigerl, K.A., McGaughy, V.M., and Popovich, P.G. (2006). Comparative analysis of lesion development and intraspinal inflammation in four strains of mice following spinal contusion injury. J. Comp. Neurol. 494, 578-594.
23. Kipnis, J., Avidan, H., Markovich, Y., Mizrahi, T., Hauben, E., Prigozhina, T.B., Slavin, S., and Schwartz, M. (2004). Lowdose gamma-irradiation promotes survival of injured neurons in the central nervous system via homeostasis-driven proliferation of T cells. Eur. J. Neurosci. 19, 1191-1198.
24. Kipnis, J., Mizrahi, T., Hauben, E., Shaked, I., Shevach, E., and Schwartz, M. (2002). Neuroprotective autoimmunity: Naturally occurring CD4+ CD25 + regulatory T cells suppress the ability to withstand injury to the central nervous system. Proc. Natl. Acad. Sci. U.S.A. 99, 15,620-15,625.
25. Kohm, A.P., McMahon, J.S., Podojil, J.R., Begolka, W.S., De-Gutes, M., Kasprowicz, D.J., Ziegler, S.F., and Miller, S.D. (2006). Cutting Edge: Anti-CD25 monoclonal antibody injection results in the functional inactivation, not depletion, of CD4 + CD25 + T regulatory cells. J. Immunol. 176, 3301-3305.
26. Lee, S.M., Yune, T.Y., Kim, S.J., Park, D.W., Lee, Y.K., Kim, Y.C., Oh, Y.J., Markelonis, G.J., and Oh, T.H. (2003). Minocycline reduces cell death and improves functional recovery after traumatic spinal cord injury in the rat. J. Neurotrauma 20, 1017-1027.
27. McPhail, L.T., Stirling, D.P., Tetzlaff, W., Kwiecien, J.M., and Ramer, M.S. (2004). The contribution of activated phagocytes and myelin degeneration to axonal retraction/dieback following spinal cord injury. Eur. J. Neurosci. 20, 1984-1994.
28. Norenberg, M.D., Smith, J., and Marcillo, A. (2004). The pathology of human spinal cord injury: Defining the problems. J. Neurotrauma 21, 429-440.
29. Ozaktay, A.C., Cavanaugh, J.M., Asik, I., DeLeo, J.A., and Weinstein, J.N. (2002). Dorsal root sensitivity to interleukin-1 beta, interleukin-6 and tumor necrosis factor in rats. Eur. Spine J. 11, 467-475.
30. Pineau, I., and Lacroix, S. (2007). Proinflammatory cytokine synthesis in the injured mouse spinal cord: Multiphasic expression pattern and identification of the cell types involved. J. Comp. Neurol. 500, 267-285.
31. Pineau, I., Sun, L., Bastien, D., and Lacroix, S. (2010) Astrocytes initiate inflammation in the injured mouse spinal cord by promoting the entry of neutrophils and inflammatory monocytes in an IL-1 receptor/MyD88-dependent fashion. Brain Behav. Immun. 24, 540-553.
32. Popovich, P., and McTigue, D. (2009). Damage control in the nervous system: Beware the immune system in spinal cord injury. Nat. Med. 15, 736-737.
33. Popovich, P.G., Guan, Z., McGaughy, V., Fisher, L., Hickey, W.F., and Basso, D.M. (2002). The neuropathological and behavioral consequences of intraspinal microglial/macrophage activation. J. Neuropathol. Exp. Neurol. 61, 623-633.
34. Popovich, P.G., Guan, Z., Wei, P., Huitinga, I., van, R.N., and Stokes, B.T. (1999). Depletion of hematogenous macrophages promotes partial hindlimb recovery and neuroanatomical repair after experimental spinal cord injury. Exp. Neurol. 158, 351-365.
35. Rabchevsky, A.G., and Streit, W.J. (1997). Grafting of cultured microglial cells into the lesioned spinal cord of adult rats enhances neurite outgrowth. J. Neurosci. Res. 47, 34-48.
36. Riegger, T., Conrad, S., Liu, K., Schluesener, H.J., Adibzahdeh, M., and Schwab, J.M. (2007). Spinal cord injury-induced immune depression syndrome (SCI-IDS). Eur. J. Neurosci. 25, 1743-1747.
37. Riegger, T., Conrad, S., Schluesener, H.J., Kaps, H.P., Badke, A., Baron, C., Gerstein, J., Dietz, K., Abdizahdeh, M., and Schwab, J.M. (2009). Immune depression syndrome following human spinal cord injury (SCI): A pilot study. Neuroscience 158, 1194-1199.
38. Rosenberg, L.J., Zai, L.J., and Wrathall, J.R. (2005). Chronic alterations in the cellular composition of spinal cord white matter following contusion injury. Glia 49, 107-120.
39. Salazar, D.L., Uchida, N., Hamers, F.P., Cummings, B.J., and Anderson, A.J. (2010). Human neural stem cells differentiate and promote locomotor recovery in an early chronic spinal cord injury NOD-scid mouse model. PLoS One 5, e12272.
40. Sroga, J.M., Jones, T.B., Kigerl, K.A., McGaughy, V.M., and Popovich, P.G. (2003). Rats and mice exhibit distinct inflammatory reactions after spinal cord injury. J. Comp. Neurol. 462, 223-240.
41. Stirling, D.P., Khodarahmi, K., Liu, J., McPhail, L.T., McBride, C.B., Steeves, J.D., Ramer, M.S., and Tetzlaff, W. (2004). Minocycline treatment reduces delayed oligodendrocyte death, attenuates axonal dieback, and improves functional outcome after spinal cord injury. J. Neurosci. 24, 2182-2190.
42. Stirling, D.P., Koochesfahani, K.M., Steeves, J.D., and Tetzlaff, W. (2005). Minocycline as a neuroprotective agent. Neuroscientist 11, 308-322.
43. Streit, W.J., Semple-Rowland, S.L., Hurley, S.D., Miller, R.C., Popovich, P.G., and Stokes, B.T. (1998). Cytokine mRNA profiles in contused spinal cord and axotomized facial nucleus suggest a beneficial role for inflammation and gliosis. Exp. Neurol. 152, 74-87.
44. Teng, Y.D., Choi, H., Onario, R.C., Zhu, S., Desilets, F.C., Lan, S., Woodard, E.J., Snyder, E.Y., Eichler, M.E., and Friedlander, R.M. (2004). Minocycline inhibits contusion-triggered mitochondrial cytochrome c release and mitigates functional deficits after spinal cord injury. Proc. Natl. Acad. Sci. U.S.A. 101, 3071-3076.
45. Weaver, L.C., Gris, D., Saville, L.R., Oatway, M.A., Chen, Y., Marsh, D.R., Hamilton, E.F., and Dekaban, G.A. (2005). Methylprednisolone causes minimal improvement after spinal cord injury in rats, contrasting with benefits of an anti-integrin treatment. J. Neurotrauma 22, 1375-1387.
46. Wells, J.E., Hurlbert, R.J., Fehlings, M.G., and Yong, V.W. (2003). Neuroprotection by minocycline facilitates significant recovery from spinal cord injury in mice. Brain 126, 1628-1637.
47. Yang, L., Blumbergs, P.C., Jones, N.R., Manavis, J., Sarvestani, G.T., and Ghabriel, M.N. (2004). Early expression and cellular localization of proinflammatory cytokines interleukin-1beta, interleukin-6, and tumor necrosis factor-alpha in human traumatic spinal cord injury. Spine (Phila Pa 1976). 29, 966-971.
48. Yong, V.W., and Rivest, S. (2009). Taking advantage of the systemic immune system to cure brain diseases. Neuron 64, 55-60.
49. Yune, T.Y., Lee, J.Y., Jung, G.Y., Kim, S.J., Jiang, M.H., Kim, Y.C., Oh, Y.J., Markelonis, G.J., and Oh, T.H. (2007). Minocycline alleviates death of oligodendrocytes by inhibiting pro-nerve growth factor production in microglia after spinal cord injury. J. Neurosci. 27, 7751-7761.